Should I sell my NVO share of 132.88?

**Consider Selling Your NVO Shares**: Based on the analysis, it appears that selling your Novo Nordisk (NVO) shares could be a prudent decision at this time. Here's why:

1. **Recent Performance**: NVO has experienced a decrease of 0.37% compared to the previous day, which may indicate a potential reversal in the stock's upward trend.
2. **Analyst Ratings and Price Targets**: The average analyst price target is $144.36, with a high forecast of $166.00 and a low forecast of $82.50. This suggests that there is potential for the stock to appreciate in value, but it is currently trading below the average target, which could be a sign to sell and avoid potential underperformance.
3. **Market Dynamics**: The stock has outpaced the S&P 500's daily loss, and its 52-week range is from $77.96 to $148.15. However, it is important to note that the stock is currently trading near the lower end of this range, which could be a signal to consider selling.
4. **Dividend Yield**: The dividend yield is 0.74%, which is a positive aspect if you are looking for income from your investment.

In conclusion, if you are looking for a strategic selling point, the current situation with NVO shares trading below the average analyst price target and near the lower end of the 52-week range, combined with a slight recent underperformance, suggests that selling could be a viable option. However, it is important to consider your personal investment strategy, risk tolerance, and the potential for the stock to rebound before making a decision.